GlobeNewswire Inc | Jun 2, 2021 08:04AM EDT

June 02, 2021

TEL AVIV, Israel, June 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR) developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by Carotid Artery Disease (CAD), announced today that Chief Executive Officer Marvin Slosman will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 10, 2021.

Mr. Slosman will deliver his corporate presentation on June 9 at 11:30am ET, Track 3.

Investors can register to watch the presentation here.

Investors interested in scheduling a meeting with management should contactassistant@ldmicro.com.

About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes.

InspireMDs common stock is quoted on the Nasdaq-CM under the ticker symbol NSPR. The Companys warrants, NSPR.WS and NSPR.WSB, currently traded on the NYSE: American, have been approved for listing on The Nasdaq Capital Market (Nasdaq). Trading is expected to begin onJune 8, 2021, under the symbols NSPRW and NSPRZ on the Nasdaq.

Investor Contacts:Craig ShoreChief Financial OfficerInspireMD, Inc.888-776-6804craigs@inspiremd.com

CORE IRinvestor-relations@inspiremd.com